Ibogaine is discussed in very different ways: as a substance, as a marketed product, as part of a treatment setting, and as a subject of scientific interest. Our plain-language overview of ibogaine access in Holland starts by keeping those categories apart, because an unscheduled status does not by itself establish lawful marketing, medical authorization, or safety.
The information services below are designed for prospective participants, families, and cross-border visitors who need a calmer way to review claims. They reflect the purpose described in Canal Lark’s approach and standards: independence, plain language, risk clarity, legal accuracy, and evidence before claims.
“Access” is not one answer. It is a set of legal, practical, and safety questions that should not be collapsed into a single label.